QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ef-hutton-maintains-buy-on-enovix-maintains-24-price-target

EF Hutton analyst Tim Moore maintains Enovix (NASDAQ:ENVX) with a Buy and maintains $24 price target.

 craig-hallum-maintains-buy-on-enovix-lowers-price-target-to-15

Craig-Hallum analyst Anthony Stoss maintains Enovix (NASDAQ:ENVX) with a Buy and lowers the price target from $20 to $15.

 whats-going-on-with-enovix-stock-after-earnings

Enovix said quarterly sales came in at $5.272 million, beating the analyst consensus estimate of $3.779 million by 39.53% and r...

 carvana-enovix-pfizer-nio-tesla-why-these-5-stocks-are-on-investors-radars-today

Wednesday saw a mixed performance in major U.S. indices. The Dow Jones Industrial Average closed the day with a 0.2% increase a...

 enovix-stock-soars-on-blockbuster-q1-sales

Enovix reports quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 29 cents by 6.9%.

 enovix-q1-2024-adj-eps-031-misses-029-estimate-sales-5272m-beat-3779m-estimate

Enovix (NASDAQ:ENVX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.29) by 6...

 b-riley-securities-maintains-buy-on-enovix-lowers-price-target-to-16

B. Riley Securities analyst Christopher Souther maintains Enovix (NASDAQ:ENVX) with a Buy and lowers the price target from $...

 where-enovix-stands-with-analysts
Where Enovix Stands With Analysts
04/26/2024 16:01:14

 jp-morgan-maintains-overweight-on-enovix-lowers-price-target-to-12

JP Morgan analyst Bill Peterson maintains Enovix (NASDAQ:ENVX) with a Overweight and lowers the price target from $18 to $12.

 cantor-fitzgerald-reiterates-overweight-on-enovix-maintains-30-price-target

Cantor Fitzgerald analyst Derek Soderberg reiterates Enovix (NASDAQ:ENVX) with a Overweight and maintains $30 price target.

 jim-cramer-is-willing-to-let-this-pharma-stock-catch-fire-advises-not-to-sell-mckesson

The "Mad Money" host recommended buying some Marvell Technology, and then wait until under $60 to buy the rest.

 enovix-stock-is-ripping-higher-tuesday-whats-going-on

Enovix shares are trading higher Tuesday after the company announced that it hit new milestones for its Fab2 manufacturing faci...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION